PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23761079-9	2013	Treatment with HCPT increased the expression of glucose-regulated protein 78 (GRP78), phospho-PERK, activating transcription factor 6 (ATF6), phosphoinositol-requiring kinase 1 (IRE1), C/EBP homologous protein (CHOP), Bax, and phospho-c-Jun N-terminal kinase (JNK) and decreased the expression of Bcl-2.	hydroxycamptothecinum	15-19	activating transcription factor 6	Homo sapiens	100-133	
33397415-0	2021	The role of activating transcription factor 6 in hydroxycamptothecin-induced fibroblast autophagy and apoptosis.	hydroxycamptothecinum	49-68	activating transcription factor 6	Homo sapiens	12-45	
33397415-3	2021	This study aimed to investigate the role of activating transcription factor 6 (ATF-6) in the HCPT-induced inhibition of fibroblast viability.	hydroxycamptothecinum	93-97	activating transcription factor 6	Homo sapiens	44-77	
33397415-3	2021	This study aimed to investigate the role of activating transcription factor 6 (ATF-6) in the HCPT-induced inhibition of fibroblast viability.	hydroxycamptothecinum	93-97	activating transcription factor 6	Homo sapiens	79-84	
33397415-7	2021	As a result, ATF6-mediated ERS played a role in HCPT-induced fibroblast apoptosis.	hydroxycamptothecinum	48-52	activating transcription factor 6	Homo sapiens	13-17	
23761079-9	2013	Treatment with HCPT increased the expression of glucose-regulated protein 78 (GRP78), phospho-PERK, activating transcription factor 6 (ATF6), phosphoinositol-requiring kinase 1 (IRE1), C/EBP homologous protein (CHOP), Bax, and phospho-c-Jun N-terminal kinase (JNK) and decreased the expression of Bcl-2.	hydroxycamptothecinum	15-19	activating transcription factor 6	Homo sapiens	135-139